Author

Edmond Wong

Harvard UniversityORCID 0000-0001-6037-7377Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

David T. MyersiD· 2 shared Sarah PhatiD· 2 shared Anna F. FaragoiD· 1 shared Benjamin J. DrapkiniD· 1 shared Braeden Freitas· 1 shared Camilla L. Christensen· 1 shared Catherine B. MeadoriD· 1 shared Collin GilbreathiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

David T. MyersORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 6, 2026

Genetic dissection of DNA damage response pathways reveals divergent modulation of PD-1 blockade response in colorectal cancer

Ferran Fece de la Cruz, Edmond Wong, Haley Barnes…·Ryan Bruce Corcoran

This study identifies DDR gene alterations that modulate PD-1 blockade response in MSS colorectal cancer, showing that some defects enhance immunotherapy while others reduce benefit.

DOI 10.64898/2026.10.03.756428

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 23, 2023

Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC paralogs

Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim…·Benjamin J. Drapkin

This paper identifies extrachromosomal DNA amplification of MYC paralogs as a recurrent driver of acquired cross-resistance in small cell lung cancer using patient-derived xenograft models.

DOI 10.1101/2023.06.23.546278

humanbulk RNA-seq

𝕏 PostBluesky